Radiopharm Theranostics Ltd (RAD) — Strategic Asset Allocation Index
Radiopharm Theranostics Ltd (RAD) has a Strategic Asset Allocation Index of 0.1% as of December 2025. Strategic assets (PP&E of AU$49.77K plus long-term investments of AU$-) total AU$49.77K, measured against net assets of AU$49.94 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Radiopharm Theranostics Ltd Strategic Asset Allocation Index (2022–2025)
This chart shows how Radiopharm Theranostics Ltd's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 0.1%, representing strategic assets of AU$49.77K against net assets of AU$49.94 Million AUD. See RAD free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Radiopharm Theranostics Ltd (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Radiopharm Theranostics Ltd from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Radiopharm Theranostics Ltd.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.1% | AU$53.47K | AU$53.47K | AU$0.00 | AU$42.87 Million | ▼ -0.2 pp |
| 2024 | 0.4% | AU$100.80K | AU$60.80K | AU$40.00K | AU$27.35 Million | ▲ +0.2 pp |
| 2023 | 0.1% | AU$68.33K | AU$68.33K | AU$- | AU$45.58 Million | ▲ +0.1 pp |
| 2022 | 0.0% | AU$1.58K | AU$1.58K | AU$- | AU$62.96 Million | — |